Biotechnology News

April 20, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the dosing of the third patient in its Phase I/II trial for dry age-related macular...

April 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today positive results from its Phase I clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the...

April 20, 2012

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, Inc. announced that new data from the company’s multiple sclerosis portfolio will be presented at the American Academy of Neurology’s 64th Annual Meeting.

April 20, 2012

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Boehringer Ingelheim announced today the launch of the GLORIATM-AF Registry Program, which is set to become the largest worldwide registry with the aim of understanding the long-term use of oral...

April 20, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: At Vitrolife’s Annual General Meeting yesterday, April 19, the following, amongst other things, was decided: · The Board’s proposed dividend of SEK 0.60 per share for the financial year 2011 was...

April 20, 2012

SADDLE BROOK, N.J. & AACHEN, Germany--(BUSINESS WIRE)--CircuLite today announced updated clinical data related to the Synergy miniature ventricular support system, as well as the successful implantation of Synergy in its 51st patient.

April 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced today that 12 data presentations from the company’s MS clinical trial programs for alemtuzumab and teriflunomide will be featured at the AAN annual meeting.

April 19, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--The OPUS Health division of Cegedim Relationship Management today announced the expansion of its patient acquisition and retention portfolio. OPUS Health’s newest solution allows pharmaceutical manufacturers to...

April 19, 2012

SALT LAKE CITY--(BUSINESS WIRE)--The U.S. healthcare system suffers from a glaring, persistent need to protect patients from unsafe IV infusions. Contaminated IV lines result in unnecessary patient injuries and death, and cost hospitals billions...

April 19, 2012

SEOUL, Korea, & FAIR LAWN, N.J.--(BUSINESS WIRE)--Designation as an Orphan Drug has been granted by the US FDA to carisbamate, from SK Biopharmaceuticals, for the management of patients with infantile spasms, an Orphan Disease.

April 19, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2012 financial results will be released on Thursday, April 26, at 4:05 p.m. Eastern Time. At 5:00 p.m. Eastern Time, Gilead’s...

April 19, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) will release its first quarter 2012 financial results on Thursday, May 3, 2012, after the markets close. The announcement will be followed by a live webcast at 5:00 p.m....

April 19, 2012

URBANA, Ill.--(BUSINESS WIRE)--Sigma-Aldrich Corporation and the University of Illinois at Urbana-Champaign have entered into a licensing agreement to provide two widely-used membrane scaffold proteins used in Nanodisc technology.

April 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new survey from Cutting Edge Information finds that U.S. market access teams should pay close attention to European practices when preparing for possible managed market developments.

April 19, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today the release of ADMET Predictor™ Version 6.0 with an...

April 19, 2012

SALT LAKE CITY--(BUSINESS WIRE)--The University of Utah (UofU) and the USTAR Governing Authority today cut the ribbon on a $130 million, sustainably designed interdisciplinary research facility.

April 19, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) reports KonLin Letter’s NVLX Buy recommendation 1st target $0.50-0.60 for live cell encapsulation reconfirming target of $1-2.

April 19, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 2, 2012 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p...

April 19, 2012

SEATTLE--(BUSINESS WIRE)--Jeff Raikes, Chief Executive Officer, Bill & Melinda Gates Foundation was announced as keynote speaker for the 2012 Life Science Innovation Northwest (LSINW) conference, scheduled for July 11-12 at the Washington...

April 19, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest was interviewed by OneMedRadio covering the global regulatory strategy for BiovaxID, a personalized cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma.

April 19, 2012

NICE, France & HAMDEN, Conn.--(BUSINESS WIRE)--Iris Pharma and RxGen Announce Strategic Alliance. Iris Pharma and RxGen Partner to Deliver Seamless and Superior Drug & Medical Devices Development Services in Ophthalmology.

April 19, 2012

MILFORD, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability of the new Thermo Scientific Nalgene Rapid-Flow Filter, which enables faster filtration of cell-culture media....

April 19, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. announced that it has entered into an exclusive, worldwide licensing agreement with Cleveland Clinic to develop and commercialize a diagnostic test for cardiovascular disease risk.

April 19, 2012

AARHUS, Denmark & RICHARDSON, Texas--(BUSINESS WIRE)--Convey Computer and CLC bio announced today the integration of CLC bio's enterprise genomics analysis platform with Convey’s leading edge, hybrid-core servers. Recently deployed at the...

April 19, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Carestream received FDA)clearance for its CARESTREAM DRX-Revolution Mobile X-Ray System and is now accepting orders from U.S. healthcare facilities.

April 19, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration welcomes Peter Francis, MD, PhD to its senior management team as Clinical Director. “Dr....

April 19, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): First quarter in brief Sales growth was 11 percent in local currency. Sales were the highest ever for a single quarter and amounted to SEK 100 (88) million, corresponding...

April 19, 2012

GOETTINGEN, Germany--(BUSINESS WIRE)--At today’s Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved all board proposals by a large majority. Thus, the Annual Shareholders' Meeting passed the resolution to pay dividends of...

April 19, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Fingertip Formulary, the leading provider of access and insight into formulary data, announced the launch of their iPad applications today at the Academy of Managed Care Pharmacy (AMCP) annual meeting....

April 19, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa is introducing its planned MS clinical trial in Secondary Progressive Multiple Sclerosis at the American Academy of Neurology Meeting on April 24, 2012.

April 19, 2012

LEBANON, N.H.--(BUSINESS WIRE)--Adimab, LLC, a technology leader in the discovery of fully human therapeutic antibodies, today announced the initiation of two new independent research collaborations. Adimab and Gilead Sciences, Inc. (Nasdaq:GILD...

April 19, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced that Christopher L. Burnley has been appointed chief business officer. Mr...

April 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its first-quarter 2012 financial results before the market opens on Thursday, May 3, 2012.

April 19, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Restoration Robotics, Inc. today announced that their revolutionary ARTAS® System will be featured at the Orlando Live Surgery Workshop (OLSW) sponsored by the International Society of Hair Restoration...

April 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Pfizer Remained Top Pharmaceutical Company by Sales in 2011, But Novartis Should Take the Top Ranking by 2015, According to New Data from Decision Resources

April 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced that its Biologics Support Center in Framingham received a Gold certification under the Green Building Council's LEED Rating System. This is the 10th building to receive the honor.

April 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today posted solid first quarter financial results which exceeded the company’s previously issued revenue and earnings per share (EPS) guidance. For the first quarter, Baxter...

April 19, 2012

KFAR SABA, Israel--(BUSINESS WIRE)--NLT SPINE announced that its eSpin discectomy device has received CE Mark approval, enabling the company to market it in Europe.

April 19, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is announcing that the Company is to be added to the S&P SmallCap 600 Index at the close of trading on Tuesday, April 24th, 2012.

April 19, 2012

PRAGUE--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and autoimmune...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced final results from a Phase III, open-label study designed to compare the impact of two anemia management strategies on sustained...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--MSD (NYSE: MRK), known as Merck in the United States and Canada, announced final results from a Phase III, open-label study designed to compare the impact of two anaemia management strategies on sustained...

April 19, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended March 31, 2012. First Quarter Results Net earnings were $161.6 million and earnings per diluted...

April 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter today announced it will build a new state-of-the-art manufacturing facility in Georgia to support growth of its plasma-based treatments.

April 19, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has received an unsolicited proposal from GlaxoSmithKline plc (GSK) to acquire HGS for $13.00 per share in cash. The HGS Board of Directors, in...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced interim data from a Phase 2 trial (ATOMIC) examining a 12-week course of treatment with the once-daily nucleotide GS-7977 plus pegylated interferon (Peg-IFN)...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced interim data from the Phase 2 ELECTRON study examining the investigational once-daily oral agent GS-7977 plus ribavirin (RBV) in treatment-naïve patients with...

April 19, 2012

BARCELONA, Spain & INGELHEIM, Germany--(BUSINESS WIRE)--Data to be presented at The International Liver Congress on Boehringer Ingelheim's interferon-free hepatitis C data in cirrhotic patients.